AI Therapeutics Announces Appointment of Biotechnology Industry Leader David Scheer as Chairman ...
GUILFORD, Conn., July 12, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the appointment of David Scheer as Chairman
Brigette Roberts Jonathan Rothberg Global Virus Network Bioscience Innovation Advisory Committee Yale University National Organization For Rare Disorders
Source: eagletribune.com